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Production of ent-kaurene 
from lignocellulosic hydrolysate 
in Rhodosporidium toruloides
Gina M. Geiselman1,2†, Xun Zhuang1,2†, James Kirby1,2, Mary B. Tran‑Gyamfi1,2, Jan‑Philip Prahl3,4, 
Eric R. Sundstrom3,4, Yuqian Gao5, Nathalie Munoz Munoz5, Carrie D. Nicora5, Derek M. Clay1,2, Gabriella Papa3,4, 
Kristin E. Burnum‑Johnson5, Jon K. Magnuson6, Deepti Tanjore3,4, Jeffrey M. Skerker7 and John M. Gladden1,2* 
Abstract 
Background: Rhodosporidium toruloides has emerged as a promising host for the production of bioproducts from 
lignocellulose, in part due to its ability to grow on lignocellulosic feedstocks, tolerate growth inhibitors, and co‑utilize 
sugars and lignin‑derived monomers. Ent‑kaurene derivatives have a diverse range of potential applications from 
therapeutics to novel resin‑based materials.
Results: The Design, Build, Test, and Learn (DBTL) approach was employed to engineer production of the non‑native 
diterpene ent‑kaurene in R. toruloides. Following expression of kaurene synthase (KS) in R. toruloides in the first DBTL 
cycle, a key limitation appeared to be the availability of the diterpene precursor, geranylgeranyl diphosphate (GGPP). 
Further DBTL cycles were carried out to select an optimal GGPP synthase and to balance its expression with KS, requir‑
ing two of the strongest promoters in R. toruloides, ANT (adenine nucleotide translocase) and TEF1 (translational elon‑
gation factor 1) to drive expression of the KS from Gibberella fujikuroi and a mutant version of an FPP synthase from 
Gallus gallus that produces GGPP. Scale‑up of cultivation in a 2 L bioreactor using a corn stover hydrolysate resulted in 
an ent‑kaurene titer of 1.4 g/L.
Conclusion: This study builds upon previous work demonstrating the potential of R. toruloides as a robust and versa‑
tile host for the production of both mono‑ and sesquiterpenes, and is the first demonstration of the production of a 
non‑native diterpene in this organism.
Keywords: Rhodotorula, Mevalonate pathway, Diterpene, Geranylgeranyl pyrophosphate synthase, Mutant farnesyl 
pyrophosphate synthase, Metabolic engineering
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Background
The diverse terpenoid family contains over 70,000 unique 
compounds that are predominantly produced from two 
fundamental isoprenoid building blocks, the C5 prenyl 
phosphates, dimethylallyl diphosphate (DMAPP) and 
isopentenyl diphosphate (IPP), via the mevalonate (MVA) 
pathway or the 1-deoxyxylulose 5-phosphate (DXP) path-
way [1–3]. These precursors are combined to generate 
longer prenyl phosphates such as the C10 monoterpene 
precursor, geranyl diphosphate (GPP), the C15 sesquit-
erpene precursor, farnesyl diphosphate (FPP), and C20 
diterpene precursor, geranylgeranyl diphosphate (GGPP) 
[4, 5].
Diterpenes are less volatile than monoterpenes and 
sesquiterpenes, and have various industrial and biologi-
cal applications from resin-based adhesives to potential 
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new drugs [6–8]. In plants, diterpenes play diverse 
roles such as protection against pathogens and herbi-
vores [9] and production of growth regulators such as 
gibberellins [10–12]. Plants, fungi and bacteria pro-
duce gibberellins from a universal precursor, ent-kau-
rene, which may be synthesized from GGPP in a single 
step or in two steps, via the intermediate ent-copalyl 
diphosphate (CDP) [13]. Gibberellins are used as a sus-
tainable means of increasing yields and stress-tolerance 
in agriculture and floriculture but are currently expen-
sive, leading to calls for biotechnological approaches to 
reduce cost and to increase the diversity of commer-
cially available gibberellins [13, 14]. Besides serving 
as the precursor to gibberellins, ent-kaurene may also 
be transformed into a variety of bioactive derivatives, 
with a range of potential applications. Anti-microbial, 
anti-cancer, and anti-inflammatory activities are among 
the properties ascribed to kaurene-derived diterpe-
noids, such as ent-kaur-16-en-19-oic acid (kaurenoic 
acid) [15]. In traditional Chinese medicine, pharmaco-
logically active ent-kaurene diterpenoids from Isodon 
plants (Lamiaceae) are used to treat inflammation and 
cancers [16]. Finally, kaurene-derivatives may play a key 
role in the development of new renewable polymers 
[17].
Only a few studies have reported on engineering 
microbes to produce ent-kaurene. For example, kaurene 
synthase (KS) from Gibberella fujikuroi was expressed 
in Aspergillus nidulans and although ent-kaurene pro-
duction was demonstrated, it was not quantified [18]. In 
another study, CDP synthase and KS from Stevia rebau-
diana were expressed in Escherichia coli along with three 
genes from the native DXP pathway, yielding 578  mg/L 
ent-kaurene from a glycerol-based (20 g/L) medium in a 
1 L bioreactor [19]. To develop a truly sustainable solu-
tion for microbial production of bioproducts, the next 
step is to transition preliminary findings from studies like 
these to microbial hosts capable of utilizing cheap renew-
able carbon sources that do not compete with our food 
supply, such as lignocellulose.
Lignocellulose poses a challenge in that it is difficult to 
deconstruct into fermentable carbon, and many decon-
struction technologies can produce toxic molecules that 
inhibit microbial growth and productivity. Much work 
has been done to develop technologies for efficient lig-
nocellulose deconstruction and generation of non-toxic 
hydrolysates that are easily converted into bioproducts 
by microbial hosts capable of consuming lignocellulosic 
sugars. For example, a process was recently developed 
that generates clean lignocellulosic hydrolysates, called 
DMR-EH, with low concentrations of microbial growth 
inhibitors such as acetate, furfural, and 5-hydroxymethyl-
furfural and up to 230 g/L of monomeric sugars [20, 21]. 
This hydrolysate has been used to produce other terpene 
bioproducts, such as 1,8-cineole in a robust microbial 
host, Rhodosporidium toruloides [22].
Rhodosporidium toruloides, has emerged as a promis-
ing host for the utilization of lignocellulosic feedstocks, 
in part because it can withstand osmotic stress [23] and 
potential growth inhibitors found in biomass hydro-
lysates [24]. In addition, R. toruloides adapts well to 
the mixed carbon sources in low-cost lignocellulosic 
feedstocks, utilizing mixtures of C5 and C6 sugars in 
combination with lignin-derived compounds such as 
p-coumarate [25, 26]. R. toruloides can be grown to high 
cell densities, surpassing 150 g/L dry cell weight in high-
gravity fermentation [27]. To date, R. toruloides has been 
engineered to produce a number of bioproducts, includ-
ing lipids, the terpene biofuel candidates 1,8-cineole and 
bisabolene, and the non-ribosomal peptide, indigoidine 
[22, 26, 28, 29]. This work explores the potential for R. 
toruloides to produce diterpene products from lignocel-
lulosic biomass, targeting the production of ent-kaurene 
from corn stover DMR-EH hydrolysate.
Results
To produce ent-kaurene in R. toruloides, we selected kau-
rene synthase from Gibberella fujikuroi (GfKS) [30, 31] 
because it generates ent-kaurene directly from GGPP 
(Fig. 1) [13]. In plant and bacterial systems, ent-kaurene 
is synthesized from GGPP in a two-step process, via CDP, 
while G. fujikuroi and other fungi contain bifunctional 
CDP/KS enzymes that generate ent-kaurene directly 
from GGPP (Fig. 1) [13]. The native promoters GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase) and ANT 
(adenine nucleotide translocase) were chosen for heter-
ologous expression of GfKS based on analysis of RNAseq 
data from a previous study that suggests that they both 
are constitutive and drive a high level of gene expression 
[32].
Constructs were transformed into R. toruloides by 
Agrobacterium tumefaciens mediated transformation 
(ATMT), which results in random chromosomal inte-
gration of transgenes. Typically, 40 transformants were 
selected for initial measurement of ent-kaurene pro-
duction and then the three highest-titer strains for each 
construct were compared in triplicate. Following screen-
ing of strains transformed with constructs harboring 
 PANT-GfKS (construct 1) and  PGAPDH-GfKS (construct 
2), we found that similar maximum ent-kaurene titers of 
15-20 mg/L were reached in  YPD10 medium (YPD con-
taining 100  g/L glucose; Fig.  2; constructs are listed in 
Table 1). The low ent-kaurene titers observed relative to 
other heterologous terpenes produced in this organism 
(typically several hundred mg/L) suggests that the avail-
ability of the GfKS substrate, GGPP, may be limiting. 
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Although R. toruloides produces carotenoids, they are 
produced at relatively low levels, indicating that native 
carbon flux to GGPP may be low [26].
Similar maximum titers were reached following trans-
formation of R. toruloides with the  PANT-GfKS and 
 PGAPDH-GfKS constructs, even though the ANT promoter 
is natively stronger, as indicated by ANT transcript lev-
els and reporter studies [32]. To test whether this relative 
difference in promoter strength also applies to expression 
of the heterologous KS, GfKS copy number, transcript 
levels, and protein levels were measured for selected 
GfKS strains (Fig. 3). In strains harboring GfKS at similar 
copy numbers, GfKS transcript and protein levels were 
higher when expressed from  PANT (strains ABFPUB_18 
and 30) than from  PGAPDH (strain ABFPUB_16). In one 
 PGAPDH-GfKS strain, ABFPUB_15, GfKS transcript and 
protein levels are higher, but this is likely due to the two- 
to threefold higher GfKS copy number in ABFPUB_15.
Comparison of transcript and protein levels of KS with 
ent-kaurene titers can also give an indication of whether 
gene expression or metabolite pools are limiting ent-kau-
rene production. The  PGAPDH-GfKS strain ABFPUB_16 
had the lowest transcript and protein levels of the strains 
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Fig. 1 Production of ent‑kaurene from acetyl‑CoA via the mevalonate pathway. Genes expressed in R. toruloides are listed in Table 1. Mutant FPP 
synthases employed in this study are designed to alter prenyl phosphate product chain length, resulting in enzymes that generate mainly GGPP 
from IPP and DMAPP, instead of the native FPP product
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Fig. 2 Expression of kaurene synthase from Gibberella fujikuroi (GfKS) 
in R. toruloides. Ent‑kaurene titer at 9 days is shown for the three 
highest‑titer strains transformed with constructs 1  (PANT‑GfKS) and 2 
 (PGAPDH‑GfKS). (N = 3, data shown as average ± standard deviation, 
from a single experiment in  YPD10 medium. ABFPUB identification 
numbers are listed in Table 1.)
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examined. While other strains (e.g., the  PANT-GfKS strain 
ABFPUB_30) had two- to fourfold higher transcript and 
protein levels, no substantial improvement in ent-kau-
rene titers was observed (Figs.  2 and 3). This indicates 
that a further increase in KS expression is not likely to 
significantly improve ent-kaurene production.
To investigate the possibility that GGPP levels may be 
a major factor limiting ent-kaurene titers, several GGPP 
synthases (GGPPSs) were selected for expression in a 
strain harboring GfKS. ABFPUB_16 was selected as a base 
strain, as it ranked most consistently as a low-variance, 
top-titer strain among the 80 GfKS transformants assayed 
in repeated screening trials. The native promoter TEF1 
(translational elongation factor 1) was chosen to express 
each of four candidate GGPPSs: the native R. toruloides 
GGPPS (construct 6,  PTEF1-RtBTS1); a mutant of the R. 
toruloides farnesyl pyrophosphate (FPP) synthase (con-
struct 3,  PTEF1-RtERG20(F91C)); a mutant GGPPS from 
Taxus canadensis (construct 4,  PTEF1-TcGGPPS(S239C, 
G295D)); and a mutant FPP synthase from Gallus gallus 
(construct 5,  PTEF1-GgFPS(F112A)). The mutations, F91C 
and F112A, introduced to the R. toruloides and G. gallus 
Table 1 Overview of constructs used to engineer ent-kaurene production in R. toruloides 
Strains and plasmids used in this study are available upon request through the Agile BioFoundry Strain Registry (http://publi c-regis try.agile biofo undry .org// [37])
GAPDH glyceraldehyde 3-phosphate dehydrogenase, ANT, adenine nucleotide translocase, TEF1 translational elongation factor, GfKS, Gibberella fujikuroi kaurene 
synthase (NCBI Accession Number, Q9UVY5), RtERG20(F91C) mutant farnesyl pyrophosphate synthase from R. toruloides (PRQ75922.1), TcGGPPS(S239C,G295D) mutant 
geranylgeranyl pyrophosphate synthase from Taxus canadensis (AAD16018), GgFPS(F112A) mutant farnesyl pyrophosphate synthase from Gallus gallus (P08836.2) and 
RtBTS1 geranylgeranyl pyrophosphate synthase BTS1 from R. toruloides (PRQ72579)
Plasmids Genotypes/features ABFPUB registry ID
Construct 1 PANT‑GfKS‑HYG
R ABFPUB_1
Construct 2 PGAPDH‑GfKS‑NAT
R ABFPUB_3
Construct 3 PTEF1‑RtERG20(F91C)‑KanMX
R ABFPUB_6
Construct 4 PTEF1‑TcGGPPS(S239C,G29D)‑KanMX
R ABFPUB_7
Construct 5 PTEF1‑GgFPS(F112A)‑KanMX
R ABFPUB_8
Construct 6 PTEF1‑RtBTS1‑KanMX
R ABFPUB_9
Construct 7 PANT‑GfKS‑PTEF1‑RtERG20(F91C)‑NAT
R ABFPUB_10
Construct 8 PANT‑GfKS‑PTEF1‑TcGGPPS(S239C, G295D)‑NAT
R ABFPUB_11
Construct 9 PANT‑GfKS‑PTEF1‑GgFPS(F112A)‑NAT
R ABFPUB_12
Construct 10 PANT‑GfKS‑PTEF1‑RtBTS1‑NAT
R ABFPUB_13
Strains IFO0880 (WT) ABFPUB_14
IFO0880/PGAPDH‑GfKS‑NAT
R ABFPUB_15–17
IFO0880/PANT‑GfKS‑HYG
R ABFPUB_18, 30, 34
IFO0880/PGAPDH‑GfKS‑NAT
R/PTEF1‑RtERG20(F91C)‑KanMX
R ABFPUB_47–49
IFO0880/PGAPDH‑GfKS‑NAT
R/PTEF1‑TcGGPPS(S239C,G29D)‑KanMX
R ABFPUB_19, 20, 31
IFO0880/PGAPDH‑GfKS‑NAT
R/PTEF1‑GgFPS(F112A)‑KanMX
R ABFPUB_32, 33, 35
IFO0880/PGAPDH‑GfKS‑NAT
R/PTEF1‑RtBTS1‑KanMX
R ABFPUB_38–40
IFO0880/PANT‑GfKS‑PTEF1‑RtERG20(F91C)‑NAT
R ABFPUB_41–43
IFO0880/PANT‑GfKS‑PTEF1‑TcGGPPS(S239C,G295D)‑NAT
R ABFPUB_21, 22, 29
IFO0880/PANT‑GfKS‑PTEF1‑GgFPS(F112A)‑NAT
R ABFPUB_23, 26, 36
IFO0880/PANT‑GfKS‑PTEF1‑RtBTS1‑NAT
R ABFPUB_44–46
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Fig. 3 Transcript level, protein level and copy number of GfKS. 
Average relative abundance of GfKS transcript (ΔCt), protein, and 
copy number on day 3. Samples are designated by their ABFPUB 
identification number and description. (N = 3, data shown as 
average ± standard deviation, from a single experiment in  YPD10 
medium.)
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FPP synthases, respectively, are designed to alter prenyl 
phosphate product chain length, resulting in enzymes 
that predominantly generate GGPP instead of the native 
FPP product [33]. The mutations S239C and G295D were 
previously identified in a carotenoid-based screen for 
improvements to the T. canadensis GGPPS [34]. Over-
expression of RtERG20(F91C) (construct 3) generally 
resulted in titers that were lower than or, at best, match-
ing those of the parent strain ABFPUB_16, perhaps due 
to an unfavorable balance between FPP and GGPP bio-
synthesis, unintended enzyme inactivation due to muta-
tion of the F91 residue, or feedback regulation of the 
native RtERG20 gene in R. toruloides (Fig.  4). However, 
overexpression of either the native R. toruloides GGPPS 
(construct 6) or the mutant GGPPS from T. canadensis 
(construct 4) resulted in more than two- and threefold 
increases in ent-kaurene titer, respectively. The most suc-
cessful strategy was overexpression of the mutant FPP 
synthase from G. gallus (construct 5), which yielded a 
17-fold increase in ent-kaurene titer, to 345  mg/L, in 
 YPD10 medium. These results indicate that overexpres-
sion of GGPPS increases the available pool of GGPP for 
KS, resulting in an improvement in ent-kaurene titers.
Optimizing carbon flux through a biosynthetic path-
way requires balancing the expression of each pathway 
enzyme. The overexpression of GGPPS alongside KS 
shifted the balance of the pathway and resulted in an 
increase in ent-kaurene titers. To test whether this shift 
in pathway balance has caused KS to become a limit-
ing factor, designs were made to balance KS and GGPPS 
expression by incorporating each  PTEF1-GGPPS and 
 PANT-GfKS in a 1:1 ratio in the same construct.  PANT was 
chosen over  PGAPDH in an attempt to restore any potential 
deficit in KS expression in the stacked KS GGPPS strains. 
After transformation into WT R. toruloides by ATMT, 
relative performance of the four GGPPSs was observed 
to remain the same but higher absolute ent-kaurene titers 
were achieved with GfKS expression under control of 
 PANT, suggesting that the KS may have become limiting 
as GGPP supply increased (Fig. 5). Co-transformation of 
 PANT-GfKS with  PTEF1-TcGGPPS(S239C, G295D) (con-
struct 8) and  PTEF1-GgFPS(F112A) (construct 9), resulted 
in ent-kaurene titers of 184 and 531  mg/L in  YPD10 
medium, respectively.
In order to understand how co-expression of KS and 
GGPPS in a single construct affected expression of each 
of these enzymes relative to iteratively stacking individ-
ual constructs into R. toruloides, transgene copy num-
ber, transcript and protein abundances of GfKS and 
GgFPS(F112A) were compared in three high-titer strains 
(Fig.  6). Transgene copy number was three- to fourfold 
higher in strains ABFPUB_23 and ABFPUB_26, which 
were generated by transformation of a single construct, 
relative to strain ABFPUB_35, which was constructed 
by gene stacking—transformation of ABFPUB_16 with 
 PTEF1-GgFPS(F112A). Interestingly, GfKS protein level 
is similar in all three strains, while and GgFPS(F112A) 
protein level is higher in strains ABFPUB_23 and ABF-
PUB_26 than in strain ABFPUB_35. Overall, the highest 
average ent-kaurene titer was achieved in strain ABF-
PUB_26, which had the highest GgFPS(F112A) protein 
level.
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Fig. 4 Co‑expression of kaurene synthase from Gibberella fujikuroi (GfKS) and various GGPP synthases in R. toruloides. Strains were constructed by 
transformation of strain ABFPUB_16  (PGAPDH‑GfKS) with constructs 3 to 6. Ent‑kaurene titer at 9 days is shown for the three highest‑titer strains for 
each construct. (N = 3, data shown as average ± standard deviation, from a single experiment in  YPD10 medium. ABFPUB identification numbers are 
listed in Table 1.)
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One of the advantages of R. toruloides as a host is its 
ability to grow on lignocellulosic hydrolysates and to 
perform well when cultivated in bioreactors [26, 35]. To 
demonstrate production of ent-kaurene from lignocel-
lulose, DMR-EH hydrolysate was prepared from corn 
stover as described previously [21]. Strain ABFPUB_26 
(harboring  PANT-GfKS and  PTEF1-GgFPS(F112A)) was 
selected for scale-up to a 2 L bioreactor in a medium 
composed of 75% corn stover DMR-EH hydrolysate, sup-
plemented with 10  g/L yeast extract. Under these con-
ditions, an ent-kaurene titer of 1.44  g/L was achieved 
(Fig. 7).  OD600 and titer increased proportionally, reach-
ing an  OD600 of 70 by 281  h; glucose was completely 
consumed by 161 h and xylose was fully consumed after 
207  h. Strain ABFPUB_26 had produced ent-kaurene at 
531  mg/L when cultivated in  YPD10 medium in culture 
tubes, yet produced 2.7 fold more ent-kaurene when 
scaled up to a 2 L bioreactor and 75% DMR-EH growth 
medium, which contains only 13% more sugar (76  g/L 
glucose and 37 g/L xylose) than  YPD10. This underscores 
the compatibility of R. toruloides with lignocellulosic 
feedstocks.
Discussion
This work applies the Design, Build, Test, and Learn 
(DBTL) approach to engineer production of the non-
native diterpene ent-kaurene in R. toruloides. The ATMT 
transformation method used in this study promotes 
random integration of constructs into the R. toruloides 
genome, generating strains that vary in transgene inser-
tion site and copy number. The resulting variation in 
transgene expression level can be advantageous in that 
it adds an additional mechanism to adjust transgene 
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Fig. 5 Co‑transformation of kaurene synthase from Gibberella fujikuroi (GfKS) and various GGPP synthases into WT R. toruloides (constructs 7–10, 
Table 1). Ent‑kaurene titer at 9 days is shown for the three highest‑titer strains for each construct. (N = 3, data shown as average ± standard 
deviation, from a single experiment in  YPD10 medium. ABFPUB identification numbers are listed in Table 1.)
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Fig. 6 Average relative abundance of transcript (ΔCt), protein and 
copy number of a GfKS and b GfFPS(F112A) on day 3. Samples are 
designated by their ABFPUB identification number. (N = 3, data 
shown as average ± standard deviation, from a single experiment in 
 YPD10 medium.)
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expression in pathway engineering work. However, it also 
can confound direct comparison of different engineer-
ing strategies. Fortunately, this issue can be overcome 
simply by measuring transgene copy number. For exam-
ple, a direct comparison between the ANT and GAPDH 
promoters was made in this study and we observed that 
 PANT resulted in stronger GfKS expression than  PGAPDH, 
in agreement with previous data comparing these pro-
moters [32].
Interestingly, unlike previous studies that used these 
same strong promoters to express a sesquiterpene syn-
thase to produce 100–500  mg/L of sesquiterpene, sim-
ply overexpressing GfKS resulted in almost tenfold lower 
titers of ent-kaurene [26]. Sesquiterpenes are produced 
from FPP (the immediate precursor of GGPP), which is 
a metabolite used for many cellular functions, includ-
ing biosynthesis of essential sterols such as ergosterol. In 
contrast, GGPP is used primarily for producing low levels 
of non-essential carotenoids in R. toruloides. Therefore, 
it’s not surprising that this study found evidence that the 
apparent GGPP metabolite pool is lower than that of FPP. 
This was substantiated by the significant increase in ent-
kaurene titers observed upon expression of a GGPPS. 
The variance in ent-kaurene titer in the GGPPS overex-
pression strains is relatively high, so it’s difficult to make 
conclusive comparisons, but the relative trend in titer 
suggests that higher levels of GgFPS(F112A) protein pro-
moted higher ent-kaurene titers. These results suggest 
that the increased GGPPS expression level in the strains 
generated from a single construct in the final DBTL cycle 
created a better balance in the pathway, leading to higher 
flux toward ent-kaurene. Overall, the difference in titer in 
strains harboring GGPPS constructs was relatively mod-
est, likely indicating that expression of these two terminal 
enzymes is reaching saturation.
While g/L titers of ent-kaurene were achieved by engi-
neering two pathway steps, there are many improvements 
that can be made to further improve titer, rate and yield 
(TRY). Additional investigation of the impact of GGPPS 
expression on the balance between FPP and GGPP could 
prove fruitful, either from further promoter optimiza-
tion for both KS and GGPPS expression or by examining 
other KS and GGPPS orthologs. Beyond these terminal 
steps in the biosynthetic pathway, optimization of the 
entire mevalonate pathway will likely lead to improve-
ments in TRY. There are also several broader avenues to 
explore to facilitate engineering this nascent host. For 
example, little is known about the impact of integration 
locus on expression in R. toruloides and developing a bet-
ter understanding of this topic is a high-priority for fur-
ther investigation. Other engineering tools that would be 
highly beneficial for pathway optimization include meth-
ods to downregulate competing pathways, such as lipid 
biosynthesis. To that end, the application of RNAi has 
recently been demonstrated in R. toruloides, with down-
regulation of fatty acid synthases [36]. This tool will be 
valuable for future studies.
Outside of metabolic engineering approaches, process 
optimization of cultivation conditions will be important 
to improve heterologous terpene production in R. toru-
loides. For example, optimization of DMR-EH hydro-
lysate media to eliminate the use of the yeast extract in 
favor of a more industrially-relevant nitrogen source such 
as ammonium sulfate would be ideal. Also, identification 
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of other vitamins and minerals that are limiting in DMR-
EH hydrolysates will likely improve TRY. Finally, a deeper 
exploration of cultivation conditions such as pH, mixing, 
aeration, and temperature are also needed in this rela-
tively new host organism. Even without these important 
optimizations, the final titer of 1.44 g/L achieved in this 
study is the highest reported ent-kaurene titer in any 
microbial cell factory.
Conclusion
This study builds upon previous work demonstrating 
the potential of R. toruloides as a robust and versatile 
host for the production of both mono- and sesquiterpe-
nes, and is the first demonstration of the production of a 
non-native diterpene in this organism. It provides a road-
map for rapid high-titer diterpene production in R. toru-
loides; it is possible that other diterpene synthases could 
be combined with the GGPPS GgFPS(F112A) in a single 
expression construct to achieve production of g/L quan-
tities of the diterpene. These results, in combination with 
previous studies on mono- and sesquiterpenes, indicate 
that R. toruloides is an ideal host for the production of a 
range of different heterologous terpene bioproducts from 
cheap renewable carbon sources, such as lignocellulosic 
biomass.
Materials and methods
Plasmid design and construction
Plasmids were based on a binary vector for Agrobac-
terium tumefaciens mediated transformation (ATMT) 
containing a bacterial expression cassette conferring 
resistance to kanamycin and R. toruloides expression 
cassettes conferring resistance to nourseothricin (NAT), 
G418 (KanMX) or hygromycin B (HYG) (Table 1). Cod-
ing sequences were optimized for expression in R. toru-
loides, synthesized, and cloned into ATMT plasmid 
backbones described previously [22, 28], by Genscript 
(Piscataway, NJ).
Transformation and screening of R. toruloides
Transformation of R. toruloides was achieved by ATMT 
as described previously [22]. Prior to screening, trans-
formants were grown on yeast peptone dextrose (YPD, 
BD Biosciences, 242820, San Jose, CA) agar containing 
300  μg/mL cefotaxime (TCI America, TCI-C2224-25G, 
Portland, OR) and 300  μg/mL carbenicillin (Sigma-
Aldrich, C1389-5G, St. Louis, MO) to prevent the 
growth of A. tumefaciens. Plates were grown at 30 °C for 
three days and single colonies were inoculated into cul-
ture tubes containing 5  mL lysogeny broth (LB, Miller, 
VWR, J106-500G, Radnor, PA) and cultured overnight 
at the same temperature with shaking at 200 rpm (Adolf 
Kühner AG, SBM-X, Birsfelden, Switzerland). Optical 
density (OD) was determined by measuring absorbance 
at 600  nm  (OD600) with a SpectraMax Plus 384 Micro-
plate Reader (Molecular Devices, PLUS384, San Jose, 
CA). Cultures were inoculated into 10  mL YPD at a 
1:100 dilution and a 20% (v/v) dodecane (Sigma-Aldrich, 
D221104) overlay was added to capture ent-kaurene. 
Strains were grown at 30  °C with shaking at 200  rpm 
for 9–10  days. After an initial round of screening, ent-
kaurene titer of the three highest producing strains was 
confirmed in triplicate for each construct by growth in 
 YPD10 (YPD containing 100 g/L glucose).
Quantification of ent‑kaurene
Following growth of engineered R. toruloides cultures, 
the dodecane phase was sampled and diluted 1:40 into 
dodecane containing 40  mg/L pentadecane (Sigma-
Aldrich, 76510), and analyzed by gas chromatography—
mass spectrometry (GC–MS) using an Agilent 6890 Plus 
gas chromatograph (Agilent Technologies, G1530A, 
Santa Clara, CA) connected to an Agilent 5973 Network 
mass spectrometer (Agilent Technologies, G1099A). 1 µL 
of each sample was injected by a CombiPal autosampler 
(CTC Analytics, MXY 02-00B, Zwingen, Switzerland). 
Analytes were separated on a DB-5MS column (30  m 
long, 0.25 mm internal diameter, 0.25 μm film thickness, 
Agilent Technologies, 122-5532) using the following oven 
parameters: hold for 0.5  min at an initial temperature 
of 100 °C, followed by a temperature ramp of 30 °C/min 
to 250 °C, a ramp of 10 °C/min to 270 °C, and a ramp of 
30  °C/min to 300  °C. The mass spectrometer was oper-
ated in selected ion mode, with target ions (m/z) of 70, 
85, 139 and 154. A standard curve was generated by run-
ning ent-kaurene standards at concentration range of 
5–80  µg/mL. Analysis was performed using Enhanced 
ChemStation (Agilent Technologies, MSD Chemstation 
E.02.00.493) with ent-kaurene peak areas normalized to 
peak areas for pentadecane. The ent-kaurene standard 
was a gift from Dr. Joe Chappell, University of Kentucky, 
Lexington, KY.
Cultivation at 2 L bioreactor scale
ABFPUB_26 was selected for growth in lignocellu-
losic hydrolysate at 2 L bioreactor scale. Lignocellulosic 
hydrolysate was prepared from corn stover by deacety-
lation, mechanical refining and enzymatic hydrolysis, 
as described previously, and is referred to as DMR-EH 
hydrolysate [21]. A BIOSTAT  B® fermentation system 
(Sartorius AG., Goettingen, Germany) was employed in 
batch mode, using a jacketed 2 L borosilicate glass ves-
sel  (UniVessel®, Sartorius AG, Goettingen, Germany) 
equipped with two 6-blade Rushton impellers, a dis-
solved oxygen (DO) probe (Hamilton VisiFerm DO 
225, Bonaduz, Switzerland), and a pH probe (Hamilton 
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EasyFerm Plus VP 225, Bonaduz, Switzerland). Seed cul-
tures were grown to exponential phase and then used to 
inoculate 0.75 L aqueous media (75% DMR hydrolysate, 
10 g/L yeast extract, and 30 mg/L cefotaxime), to which 
a 20% organic solvent overlay (150 mL dodecane spiked 
with 200 mg/L pentadecane as an internal standard) was 
added to capture ent-kaurene. The culture was grown at 
30  °C with aeration maintained at 0.37 LPM and agita-
tion at 400  rpm. After initial adjustment of the growth 
medium pH to 5.0, the pH was not controlled during 
growth. Process values were monitored and recorded 
using the integrated Sartorius data acquisition software 
(BioPAT MFCS/win). Sugar consumption, OD, and ent-
kaurene production were measured over a period of 
12  days. Ent-kaurene was measured by sampling of the 
dodecane phase, dilution, and analysis by GC–MS.
Determination of glucose and xylose
Sugars were quantified on a Dionex Ultimate 3000 sys-
tem UHPLC (Agilent Technologies) using an Aminex 
HPX-87H column (Bio-Rad, Hercules, CA) and Thermo 
Scientific™ RefractoMax 520 Refractive Index Detector 
(RID) held at 35  °C. Prior to analysis, samples were fil-
tered through 0.45  μm filters (VWR Centrifugal Filters) 
by centrifugation at 3000×g for 3 min. Samples were run 
for 26 min using an isocratic 4 mM sulfuric acid mobile 
phase at 0.6  mL  min−1 and 65  °C. Glucose, xylose, and 
arabinose standards were prepared and diluted to cre-
ate a 7-point calibration curve ranging from 0.0625 to 
4.0  mg  mL−1. Standards were run at the beginning and 
end of each run, and sugar concentrations were calcu-
lated using the Chromeleon 7 software package.
Targeted proteomics
Cultures were grown in culture tubes with 5  mL  YPD10 
medium and a dodecane overlay. Time points were col-
lected on day 1 and 3. Protein was extracted using a 
method based on a previously established protocol 
[38]. Each cell pellet, corresponding to 6 OD units, was 
diluted in 200  µL of  H2O and transferred to 2  mL pre-
filled Micro-Organism Lysing Mix glass bead tubes 
and bead beat in a Bead Ruptor Elite bead mill homog-
enizer (OMNI International, Kennesaw, Georgia) at 
speed 5.5 for 45  s. After bead beating, the lysate was 
immediately placed in an ice-block and then spun into 
a 4 mL tube at 1,000×g for 10 min at 4  °C. To separate 
the protein, metabolites and lipids, 1 mL cold (− 20  °C) 
chloroform:methanol mix (prepared 2:1 (v/v)) was pipet-
ted into a chloroform compatible 2 mL Sorenson MulTI™ 
SafeSeal™ microcentrifuge tubes (Sorenson bioscience, 
Salt Lake City, UT) inside an ice-block. The 200  µL of 
sample homogenate was then added to the Sorenson 
tube at a ratio of 1:5 sample:chloroform mix (2:1 (v/v)) 
and vigorously vortexed. The sample was then placed in 
the ice block for 5  min and then vortexed for 10 s fol-
lowed by centrifugation at 10,000×g for 10 min at 4  °C. 
The upper water-soluble metabolite phase and the lower 
lipid soluble phase was removed. The remaining pro-
tein interlayer had 1  mL of cold 100% methanol added 
to each, vortexed and centrifuged again at 10,000×g for 
10  min at 4  °C to pellet the protein. The methanol was 
then decanted off and the samples were placed in a fume 
hood to dry for ~ 10 min. 200 µL of an 8 M urea solution 
was added to the protein pellet and vortexed into solu-
tion. A bicinchoninic acid (BCA) assay (Thermo Scien-
tific, Waltham, MA) was performed to determine protein 
concentration. Following the assay, 10 mM dithiothreitol 
(DTT) was added to the samples and incubated at 60 °C 
for 30 min with constant shaking at 800 rpm followed by 
the addition of 40 mM iodoacetamide (IAA) with 30 min 
of room temperature incubation in the dark. Samples 
were then diluted eightfold for preparation for digestion 
with 100  mM  NH4HCO3, 1  mM  CaCl2 and sequencing 
grade trypsin (USB, Santa Clara, CA) was added to all 
protein samples at a 1:50 (w/w) trypsin-to-protein ratio 
for 3 h at 37 °C. Digested samples were desalted using a 
4-probe positive pressure Gilson GX-274 ASPEC™ sys-
tem (Gilson Inc., Middleton, WI) with Discovery C18 
50  mg/1  mL solid phase extraction tubes (Supelco, St. 
Louis, MO), using the following protocol: 3 mL of metha-
nol was added for conditioning followed by 3 mL of 0.1% 
trifluoroacetic acid (TFA) in  H2O. The samples were 
then loaded onto each column followed by 4 mL of 95:5 
water:acetonitrile, 0.1% TFA. Samples were eluted with 
1  mL 80:20 acetonitrile:water, 0.1% TFA. The samples 
were concentrated down to ~ 100 µL using a Speed Vac 
and a final BCA was performed to determine the peptide 
concentration and samples were diluted to 0.20  µg/µL 
with nanopure water for targeted proteomics analysis.
Targeted proteomics was performed via Liquid Chro-
matography (LC)–Selected Reaction Monitoring (SRM) 
approach. Five peptides per protein were initially selected 
based on their SRM suitability scores predicated by 
CONSeQuence [39, 40] software tools. All the peptides 
were further blasted to ensure their uniqueness to tar-
get proteins in the organism. Crude synthetic heavy 
isotope-labeled (e.g., 13C/15 N on C-terminal lysine and 
arginine) peptides were purchased from New England 
Peptide (Gardner, MA). Upon receiving, the crude syn-
thetic heavy peptides were mixed together and diluted 
with 0.1% formic acid in 15% acetonitrile in water to 
obtain a nominal concentration of 3  pmol/µL for each 
individual peptide. The heavy peptide mixture stock solu-
tion was aliquoted and stored at − 80 °C until further use.
To develop targeted proteomics assay, all the SRM 
precursor-fragment ion pairs (i.e., transitions) were 
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first analyzed using LC-SRM by spiking heavy pep-
tides in test samples. Three transitions per peptide 
and three peptides per protein were selected in a final 
assay based on their LC performance, MS response, 
transition interferences, endogenous peptide detect-
ability. Collision energies of transitions were obtained 
using empirical equations provided in Skyline software 
[41]. The selected peptides, their transitions and col-
lision energy in the final assay are listed in Additional 
file 1: Table S1.
Crude heavy peptide mixture stock solution was 
spiked in the 0.20 µg/µL peptide samples at a nominal 
concentration of 37.5 fmol/µL for each peptide. LC-
SRM analysis utilized a nanoACQUITY  UPLC® system 
(Waters Corporation, Milford, MA) coupled online 
to a TSQ Altis™ triple quadrupole mass spectrometer 
(Thermo Fisher Scientific). The  UPLC® system was 
equipped with an ACQUITY UPLC BEH 1.7  µm C18 
column (100  µm i.d. × 10  cm) and the mobile phases 
were (A) 0.1% formic acid in water and (B) 0.1% for-
mic acid in acetonitrile. 2 µL of sample (i.e., 0.4  µg of 
peptides) were loaded onto the column and separated 
using a 110-min gradient profile as follows (min:flow-
rate-µL/min:  %B): 0:0.4:1, 6:0.6:1, 7:0.4:1, 9:0.4:6, 
40:0.4:13, 70:0.4:22, 80:0.4:40, 85:0.4:95, 91:0.5:95, 
92:0.5:95, 93:0.5:50, 94:0.5:95, 95:0.6:1, 98:0.4:1. The LC 
column is operated with a temperature of 42  °C. The 
TSQ Altis™ triple quadrupole mass spectrometer was 
operated with ion spray voltages of 2100 ± 100 V and a 
capillary inlet temperature of 350 °C. Tube lens voltages 
were obtained from automatic tuning and calibration 
without further optimization. Both Q1 and Q3 were 
set at unit resolution of 0.7 FWHM and Q2 gas pres-
sure was optimized at 1.5 mTorr. The transitions were 
scanned with a 30  min retention time window and a 
duty cycle of 0.8 s.
All the LC-SRM data were imported into Skyline soft-
ware and the peak boundaries were manually inspected 
to ensure correct peak assignment and peak bounda-
ries. Peak detection and integration were determined 
based on two criteria: 1. The same LC retention time 
and 2. Approximately the same relative peak intensity 
ratios across multiple transitions between the light 
peptides and heavy peptide standards. The total peak 
area ratios of endogenous light peptides and their cor-
responding heavy isotope-labeled internal standards 
were then exported from Skyline software as Ratio-to-
Standard. For each peptide, the total peak area ratios 
of individual samples were normalized to the average 
total peak area ratio of all the samples. For each sample, 
protein abundance was calculated as an average of the 
normalized total peak area ratios of all three peptides 
of a protein.
Measurement of transcript levels
RNA was extracted using the Maxwell 16 AS2000 instru-
ment with a Maxwell RSC Plant RNA Kit (Promega, 
AS1500, Madison, WI). RNA was quantified with a Nan-
oDrop™ 2000 (Thermo Scientific) and 25  ng was used 
once linear range had been identified. Relative abundance 
(ΔCt) of transcript levels for GfKS was measured using 
Superscript IV One-Step RT-PCR System (Thermo Fisher 
Scientific, 12594100, Waltham, MA) with EvaGreen 
(Biotium, 31000, Hayward, CA) and a CFX96 Real-Time 
System C1000 Touch Thermal Cycler (Bio-Rad). Relative 
abundance was compared with housekeeping genes his-
tone H3 (XP_016270870.1) and actin (XP_016271443.1). 
Primers are listed in Addition file 2: Table S2.
Copy number quantification
1.5  mL aliquots were sampled from 3-day R. toruloides 
cultures, and centrifuged at 3,000×g for 5  min to pellet 
cells. Genomic DNA was harvested from the cell pellets 
using the Quick-DNA™ Fungal/Bacterial Miniprep Kit 
(Zymo Research) following the manufacturer’s instruc-
tions. Genomic DNA was quantified by using a Nan-
oDrop™ 2000 (Thermo Scientific). To determine the 
relative copy number of the introduced transgenes, quan-
titative PCR was performed using the PowerUp™ SYBR™ 
Green Master Mix (Thermo Scientific) on a CFX384 
Touch Real-Time PCR Detection System (BioRad) using 
the manufacturer’s instructions. Each reaction was set 
up in triplicate with 1 ng of genomic DNA as template. 
PCR products (approximately 1  kb) spanning the qPCR 
amplicons were amplified from genomic DNA for the 
native sequences and plasmid DNA for the transgenes. 
These PCR products were gel purified using the Qiaquick 
gel extraction kit (Qiagen) and used to generate standard 
curves for each qPCR primer set. Standard curves were 
used to calculate the copy number of transgenes relative 
to the native actin and GAPDH (EGU13160.1) genes. 
Primers are listed in Additional file 2: Table S2.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1293 4‑020‑1293‑8.
Additional file 1: Table S1. Peptide standards used to quantify GkKs and 
GgFPS(F112A) protein levels in R toruloides and their fragmentation ions. 
Additional file 2: Table S2. Primer sequences used for q‑PCR and 
qRT‑PCR.
Acknowledgements
We would like to thank Sam Coradetti and Joonhoon Kim for providing data 
analysis help, critical feedback, and resources. We would also like to thank 
the National Renewable Energy Lab for providing the DMR‑EH hydrolysate 
used in this project. A portion of this research was performed using EMSL 
(grid.436923.9), a DOE Office of Science User Facility sponsored by the Office 
Page 11 of 12Geiselman et al. Microb Cell Fact           (2020) 19:24  
of Biological and Environmental Research and located at Pacific Northwest 
National Laboratory.
Authors’ contributions
XZ, JMG, JMS, MBTG, JK, and GMG conceptualized the project and designed 
the study. GMG, XZ, JK MBTG, JPP, ERS, YG, NMM, CDN, KEBJ, DMC, and GP con‑
ducted experiments, collected data, and performed data analysis. GMG, JK, XZ, 
JPP, ERS, YG, NMM, CDN, KEBJ, DMC, GP, JKM, DT, JMS and JMG composed the 
manuscript, gave critical feedback on the manuscript and provided resources. 
All authors read and approved the final manuscript.
Funding
Sandia National Laboratories is a multi‑mission laboratory managed and 
operated by National Technology and Engineering Solutions of Sandia, 
LLC., a wholly owned subsidiary of Honeywell International, Inc., for the U.S. 
Department of Energy’s National Nuclear Security Administration under 
contract DE‑NA0003525. This research was part of the Agile BioFoundry 
(https ://agile biofo undry .org) supported by the U. S. Department of Energy, 
Energy Efficiency and Renewable Energy, Bioenergy Technologies Office, 
through contract DE‑AC02‑05CH11231 between Lawrence Berkeley National 
Laboratory and the U. S. Department of Energy. The views and opinions of 
the authors expressed herein do not necessarily state or reflect those of the 
United States Government or any agency thereof. Neither the United States 
Government nor any agency thereof, nor any of their employees, makes any 
warranty, expressed or implied, or assumes any legal liability or responsibility 
for the accuracy, completeness, or usefulness of any information, apparatus, 
product, or process disclosed, or represents that its use would not infringe 
privately owned rights. The Department of Energy will provide public access 
to these results of federally sponsored research in accordance with the DOE 
Public Access Plan (http://energ y.gov/downl oads/doe‑publi c‑acces s‑plan).
Availability of data and materials
All data generated or analyzed during this study are included in this published 
article.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Department of Energy, Agile BioFoundry, Emeryville, CA 94608, USA. 
2 Department of Biomass Science and Conversion Technology, Sandia National 
Laboratories, 7011 East Ave, Livermore, CA 94550, USA. 3 Advanced Biofuels 
and Bioproducts Process Development Unit, Lawrence Berkeley National 
Laboratory, Emeryville, CA 94608, USA. 4 Biological Systems and Engineering 
Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA. 
5 Earth and Biological Sciences Directorate, Pacific Northwest National Labora‑
tory, Richland, WA 99354, USA. 6 Energy and Environment Directorate, Pacific 
Northwest National Laboratory, Richland, WA 99354, USA. 7 QB3‑Berkeley, 
University of California, Berkeley, CA 94704, USA. 
Received: 5 September 2019   Accepted: 23 January 2020
References
 1. Li R, Chou WKW, Himmelberger JA, Litwin KM, Harris GG, Cane DE, et al. 
Reprogramming the chemodiversity of terpenoid cyclization by remold‑
ing the active site contour of epi‑isozizaene synthase. Biochemistry. 2014. 
https ://doi.org/10.1021/bi401 643u.
 2. Sacchettini JC, Poulter CD. Creating isoprenoid diversity. Science. 1997. 
https ://doi.org/10.1126/scien ce.277.5333.1788.
 3. Christianson DW. Chemistry. Roots of biosynthetic diversity. Science. 
2007. https ://doi.org/10.1126/scien ce.11416 30.
 4. Poulter CD, Rilling HC. The prenyl transfer reaction. Enzymic and mecha‑
nistic studies of the 1′‑4 coupling reaction in the terpene biosynthetic 
pathway. Acc Chem Res. 1978. https ://doi.org/10.1021/ar501 28a00 4.
 5. Poulter CD. Farnesyl diphosphate synthase. A paradigm for understand‑
ing structure and function relationships in E‑polyprenyl diphosphate 
synthases. Phytochem Rev. 2006. https ://doi.org/10.1007/s1110 
1‑005‑4887‑1.
 6. Faustino C, Neto Í, Fonte P, Macedo A. Cytotoxicity and chemotherapeu‑
tic potential of natural rosin abietane diterpenoids and their synthetic 
derivatives. Curr Pharm Des. 2018. https ://doi.org/10.2174/13816 12825 
66619 01121 62817 .
 7. Barros Alencar MVO, Castro E Sousa JM, Rolim HML, Medeiros M das GF, 
Cerqueira GS, Castro Almeida FR, et al. Diterpenes as lead molecules 
against neglected tropical diseases. Phytother Res. 2017; https ://doi.
org/10.1002/ptr.5749.
 8. Prieto JM, Silveira D. Natural cytotoxic diterpenoids, a potential source 
of drug leads for melanoma therapy. Curr Pharm Des. 2018. https ://doi.
org/10.2174/13816 12825 66619 01111 43648 .
 9. Block AK, Vaughan MM, Schmelz EA, Christensen SA. Biosynthesis and 
function of terpenoid defense compounds in maize (Zea mays). Planta. 
2019. https ://doi.org/10.1007/s0042 5‑018‑2999‑2.
 10. Xu Y, Charles MT, Luo Z, Mimee B, Tong Z, Véronneau P‑Y, et al. Ultraviolet‑
C priming of strawberry leaves against subsequent Mycosphaerella 
fragariae infection involves the action of reactive oxygen species, 
plant hormones, and terpenes. Plant Cell Environ. 2019. https ://doi.
org/10.1111/pce.13491 .
 11. Ratnadass A, Wink M. The phorbol ester fraction from Jatropha curcas 
seed oil: potential and limits for crop protection against insect pests. Int J 
Mol Sci. 2012. https ://doi.org/10.3390/ijms1 31216 157.
 12. Yamaguchi S. Gibberellin metabolism and its regulation. Annu Rev Plant 
Biol. 2008. https ://doi.org/10.1146/annur ev.arpla nt.59.03260 7.09280 4.
 13. Salazar‑Cerezo S, Martínez‑Montiel N, García‑Sánchez J, Pérez‑Y‑Terrón 
R, Martínez‑Contreras RD. Gibberellin biosynthesis and metabolism: a 
convergent route for plants, fungi and bacteria. Microbiol Res. 2018. https 
://doi.org/10.1016/j.micre s.2018.01.010.
 14. Camara MC, Vandenberghe LPS, Rodrigues C, de Oliveira J, Faulds C, 
Bertrand E, et al. Current advances in gibberellic acid (GA3) production, 
patented technologies and potential applications. Planta. 2018. https ://
doi.org/10.1007/s0042 5‑018‑2959‑x.
 15. Takahashi JA, Gomes DC, Lyra FH, Dos Santos GF, Martins LR. The remark‑
able structural diversity achieved in ent‑Kaurane Diterpenes by fungal 
biotransformations. Molecules. 2014. https ://doi.org/10.3390/molec ules1 
90218 56.
 16. Du G, Gong H‑Y, Feng K‑N, Chen Q‑Q, Yang Y‑L, Fu X‑L, et al. Diterpene 
synthases facilitating production of the kaurane skeleton of eriocalyxin B 
in the medicinal plant Isodon eriocalyx. Phytochemistry. 2019. https ://doi.
org/10.1016/j.phyto chem.2018.11.015.
 17. Hillwig ML, Mann FM, Peters RJ. Diterpenoid biopolymers: new directions 
for renewable materials engineering. Biopolymers. 2011. https ://doi.
org/10.1002/bip.21538 .
 18. Bromann K, Toivari M, Viljanen K, Ruohonen L, Nakari‑Setälä T. Engineering 
Aspergillus nidulans for heterologous ent‑kaurene and gamma‑terpinene 
production. Appl Microbiol Biotechnol. 2016. https ://doi.org/10.1007/
s0025 3‑016‑7517‑5.
 19. Kong MK, Kang H‑J, Kim JH, Oh SH, Lee PC. Metabolic engineering of 
the Stevia rebaudiana ent‑kaurene biosynthetic pathway in recombi‑
nant Escherichia coli. J Biotechnol. 2015. https ://doi.org/10.1016/j.jbiot 
ec.2015.09.016.
 20. Chen X, Shekiro J, Pschorn T, Sabourin M, Tao L, Elander R, et al. A highly 
efficient dilute alkali deacetylation and mechanical (disc) refining process 
for the conversion of renewable biomass to lower cost sugars. Biotechnol 
Biofuels. 2014. https ://doi.org/10.1186/1754‑6834‑7‑98.
 21. Chen X, Kuhn E, Jennings EW, Nelson R, Tao L, Zhang M, et al. DMR (dea‑
cetylation and mechanical refining) processing of corn stover achieves 
high monomeric sugar concentrations (230 g  L− 1) during enzymatic 
hydrolysis and high ethanol concentrations (> 10% v/v) during fermenta‑
tion without hydrolysate purification or concentration. Energy Environ 
Sci. 2016. https ://doi.org/10.1039/C5EE0 3718B .
 22. Zhuang X, Kilian O, Monroe E, Ito M, Tran‑Gymfi MB, Liu F, et al. Monoter‑
pene production by the carotenogenic yeast Rhodosporidium toruloides. 
Microb Cell Fact. 2019. https ://doi.org/10.1186/s1293 4‑019‑1099‑8.
Page 12 of 12Geiselman et al. Microb Cell Fact           (2020) 19:24 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 23. Singh G, Jawed A, Paul D, Bandyopadhyay KK, Kumari A, Haque S. 
Concomitant production of lipids and carotenoids in Rhodosporidium 
toruloides under osmotic stress using response surface methodology. 
Front Microbiol. 2016. https ://doi.org/10.3389/fmicb .2016.01686 .
 24. Hu C, Zhao X, Zhao J, Wu S, Zhao ZK. Effects of biomass hydrolysis 
by‑products on oleaginous yeast Rhodosporidium toruloides. Bioresour 
Technol. 2009. https ://doi.org/10.1016/j.biort ech.2009.04.041.
 25. Rodriguez A, Ersig N, Geiselman GM, Seibel K, Simmons BA, Magnuson 
JK, et al. Conversion of depolymerized sugars and aromatics from engi‑
neered feedstocks by two oleaginous red yeasts. Bioresour Technol. 2019. 
https ://doi.org/10.1016/j.biort ech.2019.12136 5.
 26. Yaegashi J, Kirby J, Ito M, Sun J, Dutta T, Mirsiaghi M, et al. Rhodosporidium 
toruloides: a new platform organism for conversion of lignocellulose into 
terpene biofuels and bioproducts. Biotechnol Biofuels. 2017. https ://doi.
org/10.1186/s1306 8‑017‑0927‑5.
 27. Li Y, Zhao Z, Bai F. High‑density cultivation of oleaginous yeast Rho-
dosporidium toruloides Y4 in fed‑batch culture. Enzyme Microb Technol. 
2007. https ://doi.org/10.1016/j.enzmi ctec.2007.02.008.
 28. Zhang S, Skerker JM, Rutter CD, Maurer MJ, Arkin AP, Rao CV. Engineer‑
ing Rhodosporidium toruloides for increased lipid production. Biotechnol 
Bioeng. 2016. https ://doi.org/10.1002/bit.25864 .
 29. Wehrs M, Gladden JM, Liu Y, Platz L, Prahl J‑P, Moon J, et al. Sustainable 
bioproduction of the blue pigment indigoidine: Expanding the range of 
heterologous products in R. toruloides to include non‑ribosomal peptides. 
Green Chem. 2019. https ://doi.org/10.1039/C9GC0 0920E .
 30. Zhuang X. Engineering Novel Terpene Production Platforms in the Yeast 
Saccharomyces cerevisiae. Doctoral dissertation. University of Kentucky; 
2013.
 31. Toyomasu T, Kawaide H, Ishizaki A, Shinoda S, Otsuka M, Mitsuhashi W, 
et al. Cloning of a full‑length cDNA encoding ent‑kaurene synthase from 
Gibberella fujikuroi: functional analysis of a bifunctional diterpene cyclase. 
Biosci Biotechnol Biochem. 2000. https ://doi.org/10.1271/bbb.64.660.
 32. Nora LC, Wehrs M, Kim J, Cheng J‑F, Tarver A, Simmons BA, et al. A toolset 
of constitutive promoters for metabolic engineering of Rhodosporidium 
toruloides. BioRxiv. 2019. https ://doi.org/10.1101/59277 4.
 33. Tarshis LC, Proteau PJ, Kellogg BA, Sacchettini JC, Poulter CD. Regulation 
of product chain length by isoprenyl diphosphate synthases. Proc Natl 
Acad Sci USA. 1996. https ://doi.org/10.1073/pnas.93.26.15018 .
 34. Leonard E, Ajikumar PK, Thayer K, Xiao W‑H, Mo JD, Tidor B, et al. Combin‑
ing metabolic and protein engineering of a terpenoid biosynthetic 
pathway for overproduction and selectivity control. Proc Natl Acad Sci 
USA. 2010. https ://doi.org/10.1073/pnas.10061 38107 .
 35. Sundstrom E, Yaegashi J, Yan J, Masson F, Papa G, Rodriguez A, et al. Dem‑
onstrating a separation‑free process coupling ionic liquid pretreatment, 
saccharification, and fermentation with Rhodosporidium toruloides to 
produce advanced biofuels. Green Chem. 2018. https ://doi.org/10.1039/
C8GC0 0518D .
 36. Liu X, Zhang Y, Liu H, Jiao X, Zhang Q, Zhang S, et al. RNA interference in 
the oleaginous yeast Rhodosporidium toruloides. FEMS Yeast Res. 2019. 
https ://doi.org/10.1093/femsy r/foz03 1.
 37. Ham TS, Dmytriv Z, Plahar H, Chen J, Hillson NJ, Keasling JD. Design, 
implementation and practice of JBEI‑ICE: an open source biological 
part registry platform and tools. Nucleic Acids Res. 2012. https ://doi.
org/10.1093/nar/gks53 1.
 38. Nakayasu ES, Nicora CD, Sims AC, Burnum‑Johnson KE, Kim YM, Kyle JE, 
et al. MPLEx: a robust and universal protocol for single‑sample integrative 
proteomic, metabolomic, and lipidomic analyses. Msystems. 2016. https 
://doi.org/10.1128/mSyst ems.00043 ‑16.
 39. Eyers CE, Lawless C, Wedge DC, Lau KW, Gaskell SJ, Hubbard SJ. CON‑
SeQuence: prediction of reference peptides for absolute quantitative 
proteomics using consensus machine learning approaches. Mol Cell 
Proteomics. 2011. https ://doi.org/10.1074/mcp.M110.00338 4.
 40. Searle BC, Egertson JD, Bollinger JG, Stergachis AB, MacCoss MJ. Using 
data independent acquisition (DIA) to model high‑responding peptides 
for targeted proteomics experiments. Mol Cell Proteomics. 2015. https ://
doi.org/10.1074/mcp.M115.05130 0.
 41. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen 
B, et al. Skyline: an open source document editor for creating and analyz‑
ing targeted proteomics experiments. Bioinformatics. 2010. https ://doi.
org/10.1093/bioin forma tics/btq05 4.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
